Biomimetic Nano‐Regulator that Induces Cuproptosis and Lactate‐Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell Carcinoma
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Xiaotong Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University,…. Hauptthemen laut MEDLINE: Copper, Immunotherapy, Carcinoma, Renal Cell, Lactic Acid. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Key R&D Program of Shandong Province, China, National Natural Science Foundation of China, Taishan Scholars Construction Engineering.
Abstract (Originalsprache)
Herein, a ccRCC targeting nanodrug is designed to enhance chemodynamic therapy (CDT) as well as activate cuproptosis and tumor immunotherapy via ccRCC cell membrane modifying CuO@Gd 2 O 3 yolk‐like particles (CGYL) loaded with lactate oxidase (LOx) (mCGYL‐LOx). Benefiting from the homologous targeting effect of Renca cell membranes, the mCGYS‐LOx can be effectively internalized by Renca cells, open the “gate”, and then release LOx and copper (Cu) ions. LOx can catalyze excessive lactate in Renca cells into H 2 O 2 , following that the produced H 2 O 2 is further converted by Cu ions to the highly toxic ·OH, contributing to tumor CDT. Meanwhile, the excessive Cu ions effectively trigger tumor cuproptosis. These synergistic effects induce the release of damage associated molecular patterns (DAMPs) and activate immunogenic cell death (ICD), leading to DC maturation and infiltration of immune effector cells. Moreover, LOx‐mediated lactate consumption downregulates the expression of PD‐L1, crippling tumor immune escape. In addition, the mCGYL‐LOx improves T 1 ‐weighted MRI signal, allowing for accurate diagnosis of ccRCC. This study demonstrates that the mCGYL‐LOx has great potential for improving therapy of ccRCC via the synergistic actions of CDT and cuproptosis as well as immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, P. R. China.
ORCID-Profile: Guilong Zhang
Förderung
- Key R&D Program of Shandong Province, China
- National Natural Science Foundation of China
- Taishan Scholars Construction Engineering
- Natural Science Foundation of Shandong Province
- Binzhou Medical University
Zitieren
APA
Xu, X., Li, H., Tong, B., Zhang, W., Wang, X., Wang, Y., Tian, G., Xu, Z., & Zhang, G. (2024). Biomimetic Nano‐Regulator that Induces Cuproptosis and Lactate‐Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell Carcinoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400204
Vancouver
Xu X, Li H, Tong B, Zhang W, Wang X, Wang Y, et al. Biomimetic Nano‐Regulator that Induces Cuproptosis and Lactate‐Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell Carcinoma. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400204
BibTeX
@article{Xu2024,
author = {Xu, Xiaotong and Li, Huimin and Tong, Binghua and Zhang, Weijie and Wang, Xiaofei and Wang, Yue and Tian, Geng and Xu, Zhaowei and Zhang, Guilong},
title = {Biomimetic Nano‐Regulator that Induces Cuproptosis and Lactate‐Depletion Mediated ROS Storm for Metalloimmunotherapy of Clear Cell Renal Cell Carcinoma},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400204}
}
EUVIMED